COVID-19 Testing in Patients With Vascular Disorders

CompletedOBSERVATIONAL
Enrollment

2,243

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

December 1, 2020

Study Completion Date

January 1, 2021

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

PCR

"Nasal or pharyngeal respiratory swabs were routinely taken of each patient admitted at our departments and repeated regularly at 48 h intervals during the inpatient stay.~In the HCP cohort testing for SARS-CoV-2 RNA was performed, on a weekly basis, at the Department of Laboratory Medicine, Medical University of Vienna, Austria, using real-time polymerase chain reaction (RT-PCR). Comparability of the results of all test methods used was confirmed by participation in international quality control ring trials."

Trial Locations (1)

1090

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT04838093 - COVID-19 Testing in Patients With Vascular Disorders | Biotech Hunter | Biotech Hunter